0001140361-22-032905.txt : 20220909
0001140361-22-032905.hdr.sgml : 20220909
20220909161730
ACCESSION NUMBER: 0001140361-22-032905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220907
FILED AS OF DATE: 20220909
DATE AS OF CHANGE: 20220909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GG 1978 SICAF SIF S.A. - GG Strategic
CENTRAL INDEX KEY: 0001814890
STATE OF INCORPORATION: N4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 221236400
BUSINESS ADDRESS:
STREET 1: C/O NOGRA GROUP SICAF-SIF S.A.
STREET 2: 18 AVENUE DE LA PORTE NEUVE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2227
BUSINESS PHONE: 352 26200068
MAIL ADDRESS:
STREET 1: C/O NOGRA GROUP SICAF-SIF S.A.
STREET 2: 18 AVENUE DE LA PORTE NEUVE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2227
FORMER NAME:
FORMER CONFORMED NAME: Nogra Group SICAF SIF GG Strategic
DATE OF NAME CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GG 1978 SICAF SIF S.A.
CENTRAL INDEX KEY: 0001814891
STATE OF INCORPORATION: N4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39329
FILM NUMBER: 221236399
BUSINESS ADDRESS:
STREET 1: 18 AVENUE DE LA PORTE NEUVE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2227
BUSINESS PHONE: 352 26200068
MAIL ADDRESS:
STREET 1: 18 AVENUE DE LA PORTE NEUVE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2227
FORMER NAME:
FORMER CONFORMED NAME: Nogra Group SICAF - SIF S.A.
DATE OF NAME CHANGE: 20200611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Royalty Pharma plc
CENTRAL INDEX KEY: 0001802768
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
form4.xml
FORM 4
X0306
4
2022-09-07
0001802768
Royalty Pharma plc
RPRX
0001814890
GG 1978 SICAF SIF S.A. - GG Strategic
18 AVENUE DE LA PORTE NEUVE
LUXEMBOURG
N4
L-2227
LUXEMBOURG
true
0001814891
GG 1978 SICAF SIF S.A.
18 AVENUE DE LA PORTE NEUVE
LUXEMBOURG
N4
L-2227
LUXEMBOURG
true
Class A Ordinary Shares
2022-09-07
4
S
0
250000
42.5303
D
22674176
I
See Footnotes
Class A Ordinary Shares
2022-09-08
4
S
0
248006
42.8617
D
22426170
I
See Footnotes
Reflects securities held directly by GG 1978 SICAF SIF S.A. - GG Strategic (formerly known as Nogra Group SICAF SIF GG Strategic) ("GG Strategic").
GG Strategic is a sub-fund managed and administered by GG 1978 SICAF S.A. ("GG 1978 SICAF"). A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary. The GG Trust is the 100% economic owner of the shares held by GG Strategic. Giammaria Giuliani disclaims beneficial ownership over the shares beneficially owned by GG Strategic. The trustee of the GG Trust is GISEV Trustees Limited. The protector of each of the GG Trust is Achille G. Severgnini, who has the power to remove and replace the trustee of the GG Trust.
Each of the Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the direct holder to the extent of its direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein or are subject to Section 16.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.83 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.395 to $43.155 per share, inclusive. The Reporting Persons undertake to provide to Royalty Pharma plc, any security holder of Royalty Pharma plc, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
GG 1978 SICAF SIF S.A. - GG STRATEGIC By: /s/ Achille G. Severgnini, Title: Director /s/ Marco Sterzi, Title: Director
2022-09-09
GG 1978 SICAF SIF S.A. By: /s/ Achille G. Severgnini, Title: Director /s/ Marco Sterzi, Title: Director
2022-09-09